Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Andreas M. Beyer PhD

Andreas M. Beyer PhD

Assistant Professor

Institution: Medical College of Wisconsin
Department: Medicine
Division: Cardiology
Program: Research

Member of the Cancer Center
Member of the Cardiovascular Center

I am willing to mentor a junior faculty member.

Research Experience

  • Cardiovascular Abnormalities
  • Cardiovascular Diseases
  • Coronary Artery Disease
  • DNA, Mitochondrial
  • Free Radical Scavengers
  • Free Radicals
  • Heart Diseases
  • Hypertension
  • Mitochondria
  • Mitochondrial Diseases
  • Pharmacology
  • Physiology
  • Reperfusion Injury
  • Telomerase
  • Vascular Diseases
  • MCW Program / Core Facilities

  • Cardiovascular Center
  • cancer center
  • Publications

  • PGC-1α (Peroxisome Proliferator-Activated Receptor γ Coactivator 1-α) Overexpression in Coronary Artery Disease Recruits NO and Hydrogen Peroxide During Flow-Mediated Dilation and Protects Against Increased Intraluminal Pressure. (Kadlec AO, Chabowski DS, Ait-Aissa K, Hockenberry JC, Otterson MF, Durand MJ, Freed JK, Beyer AM, Gutterman DD) Hypertension 2017 Jul;70(1):166-173 PMID: 28533333 PMCID: PMC5485836 05/24/2017
  • 5,6-δ-DHTL, a stable metabolite of arachidonic acid, is a potential EDHF that mediates microvascular dilation. (Levi-Rosenzvig R, Beyer AM, Hockenberry J, Ben-Shushan RS, Chuyun D, Atiya S, Tamir S, Gutterman DD, Szuchman-Sapir A) Free Radic Biol Med 2017 Feb;103:87-94 PMID: 28007573 12/23/2016
  • Transition in the mechanism of flow-mediated dilation with aging and development of coronary artery disease. (Beyer AM, Zinkevich N, Miller B, Liu Y, Wittenburg AL, Mitchell M, Galdieri R, Sorokin A, Gutterman DD) Basic Res Cardiol 2017 Jan;112(1):5 PMID: 27995364 12/21/2016
  • Friend or foe? Telomerase as a pharmacological target in cancer and cardiovascular disease. (Ait-Aissa K, Ebben JD, Kadlec AO, Beyer AM) Pharmacol Res 2016 Sep;111:422-433 PMID: 27394166 PMCID: PMC5026584 07/11/2016
  • Vascular Actions of Angiotensin 1-7 in the Human Microcirculation: Novel Role for Telomerase. (Durand MJ, Zinkevich NS, Riedel M, Gutterman DD, Nasci VL, Salato VK, Hijjawi JB, Reuben CF, North PE, Beyer AM) Arterioscler Thromb Vasc Biol 2016 Jun;36(6):1254-62 PMID: 27079876 PMCID: PMC4882242 04/16/2016
  • Mitochondrial signaling in the vascular endothelium: beyond reactive oxygen species. (Kadlec AO, Beyer AM, Ait-Aissa K, Gutterman DD) Basic Res Cardiol 2016 May;111(3):26 PMID: 26992928 03/20/2016
  • The Human Microcirculation: Regulation of Flow and Beyond. (Gutterman DD, Chabowski DS, Kadlec AO, Durand MJ, Freed JK, Ait-Aissa K, Beyer AM) Circ Res 2016 Jan 08;118(1):157-72 PMID: 26837746 PMCID: PMC4742348 02/04/2016
  • Critical Role for Telomerase in the Mechanism of Flow-Mediated Dilation in the Human Microcirculation. (Beyer AM, Freed JK, Durand MJ, Riedel M, Ait-Aissa K, Green P, Hockenberry JC, Morgan RG, Donato AJ, Peleg R, Gasparri M, Rokkas CK, Santos JH, Priel E, Gutterman DD) Circ Res 2016 Mar 04;118(5):856-66 PMID: 26699654 PMCID: PMC4772813 12/25/2015
  • Peptide inhibitors of Telomerase nuclear translocation and therapeutic uses thereof (Johnathan D. Ebben, Andreas M. Beyer) US Provisional Patent App- 62/211,524 08/25/2015
  • Regulation of Insulin Receptor Trafficking by Bardet Biedl Syndrome Proteins. (Starks RD, Beyer AM, Guo DF, Boland L, Zhang Q, Sheffield VC, Rahmouni K) PLoS Genet 2015 Jun;11(6):e1005311 PMID: 26103456 PMCID: PMC4478011 06/24/2015
  • H2S in the Vasculature: Controversy of Mechanisms in Physiology, Pathology and Beyond (Nishijima, Y Beyer, AM) Cardiol Pharmacol Nishijima, Y., and A. M. Beyer. "H2S in the Vasculature: Controversy of Mechanisms in Physiology, Pathology and Beyond." Cardiol Pharmacol 4.135 (2015): 24-26. 05/01/2015
  • An acute rise in intraluminal pressure shifts the mediator of flow-mediated dilation from nitric oxide to hydrogen peroxide in human arterioles. (Beyer AM, Durand MJ, Hockenberry J, Gamblin TC, Phillips SA, Gutterman DD) Am J Physiol Heart Circ Physiol 2014 Dec 01;307(11):H1587-93 PMID: 25260615 PMCID: PMC4255007 09/28/2014
  • Ceramide changes the mediator of flow-induced vasodilation from nitric oxide to hydrogen peroxide in the human microcirculation. (Freed JK, Beyer AM, LoGiudice JA, Hockenberry JC, Gutterman DD) Circ Res 2014 Aug 15;115(5):525-32 PMID: 24920698 PMCID: PMC4640193 06/13/2014
  • Response to "Does angiotensin-dependent superoxide production help to prevent salt-induced endothelial dysfunction in 2 kidney-1 clip hypertensive rats?". (Beyer AM, Fredrich K, Lombard JH) Am J Hypertens 2014 Apr;27(4):640 PMID: 24614863 PMCID: PMC4542814 03/13/2014
  • Amelioration of salt-induced vascular dysfunction in mesenteric arteries of Dahl salt-sensitive rats by missense mutation of extracellular superoxide dismutase. (Beyer AM, Raffai G, Weinberg BD, Fredrich K, Rodgers MS, Geurts AM, Jacob HJ, Dwinell MR, Lombard JH) Am J Physiol Heart Circ Physiol 2014 Feb;306(3):H339-47 PMID: 24322611 PMCID: PMC3920146 12/11/2013
  • AT1 receptors prevent salt-induced vascular dysfunction in isolated middle cerebral arteries of 2 kidney-1 clip hypertensive rats. (Beyer AM, Fredrich K, Lombard JH) Am J Hypertens 2013 Dec;26(12):1398-404 PMID: 23934707 PMCID: PMC3816625 08/13/2013
  • In-depth proteomic analysis of human tropomyosin by top-down mass spectrometry. (Peng Y, Yu D, Gregorich Z, Chen X, Beyer AM, Gutterman DD, Ge Y) J Muscle Res Cell Motil 2013 Aug;34(3-4):199-210 PMID: 23881156 PMCID: PMC3849107 07/25/2013
  • Prolonged treatment with angiotensin 1-7 improves endothelial function in diet-induced obesity. (Beyer AM, Guo DF, Rahmouni K) J Hypertens 2013 Apr;31(4):730-8 PMID: 23425706 02/22/2013
  • Dahl salt-sensitive rats are protected against vascular defects related to diet-induced obesity. (Beyer AM, Raffai G, Weinberg B, Fredrich K, Lombard JH) Hypertension 2012 Aug;60(2):404-10 PMID: 22710645 PMCID: PMC3444144 06/20/2012
  • Hexosamine pathway activation and O-linked-N-acetylglucosamine: novel mediators of endothelial dysfunction in hyperglycemia and diabetes. (Beyer AM, Weihrauch D) Vascul Pharmacol 2012 Mar-Apr;56(3-4):113-4 PMID: 22289438 02/01/2012
  • Regulation of the human coronary microcirculation. (Beyer AM, Gutterman DD) J Mol Cell Cardiol 2012 Apr;52(4):814-21 PMID: 22033434 PMCID: PMC3306504 10/29/2011
  • Inactivation of Bardet-Biedl syndrome genes causes kidney defects. (Guo DF, Beyer AM, Yang B, Nishimura DY, Sheffield VC, Rahmouni K) Am J Physiol Renal Physiol 2011 Feb;300(2):F574-80 PMID: 21106857 PMCID: PMC3043995 11/26/2010
  • Contrasting vascular effects caused by loss of Bardet-Biedl syndrome genes. (Beyer AM, Guo DF, Sheffield VC, Rahmouni K) Am J Physiol Heart Circ Physiol 2010 Dec;299(6):H1902-7 PMID: 20852044 PMCID: PMC3006278 09/21/2010
  • Bioinformatic analysis of gene sets regulated by ligand-activated and dominant-negative peroxisome proliferator-activated receptor gamma in mouse aorta. (Keen HL, Halabi CM, Beyer AM, de Lange WJ, Liu X, Maeda N, Faraci FM, Casavant TL, Sigmund CD) Arterioscler Thromb Vasc Biol 2010 Mar;30(3):518-25 PMID: 20018933 PMCID: PMC2850258 12/19/2009
  • Endothelium-specific interference with peroxisome proliferator activated receptor gamma causes cerebral vascular dysfunction in response to a high-fat diet. (Beyer AM, de Lange WJ, Halabi CM, Modrick ML, Keen HL, Faraci FM, Sigmund CD) Circ Res 2008 Sep 12;103(6):654-61 PMID: 18676352 PMCID: PMC2583077 08/05/2008
  • Germ line activation of the Tie2 and SMMHC promoters causes noncell-specific deletion of floxed alleles. (de Lange WJ, Halabi CM, Beyer AM, Sigmund CD) Physiol Genomics 2008 Sep 17;35(1):1-4 PMID: 18612081 PMCID: PMC2574738 07/10/2008
  • Interference with PPAR gamma function in smooth muscle causes vascular dysfunction and hypertension. (Halabi CM, Beyer AM, de Lange WJ, Keen HL, Baumbach GL, Faraci FM, Sigmund CD) Cell Metab 2008 Mar;7(3):215-26 PMID: 18316027 PMCID: PMC2275166 03/05/2008
  • Interference with PPARgamma signaling causes cerebral vascular dysfunction, hypertrophy, and remodeling. (Beyer AM, Baumbach GL, Halabi CM, Modrick ML, Lynch CM, Gerhold TD, Ghoneim SM, de Lange WJ, Keen HL, Tsai YS, Maeda N, Sigmund CD, Faraci FM) Hypertension 2008 Apr;51(4):867-71 PMID: 18285614 PMCID: PMC2408877 02/21/2008
  • Last update: 05/24/2017
    jenkins-FCD Prod-130 96200611f8481f0aa4f84230b11dd74d063847a3